相关实验视频

Updated: Jan 15, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

阿兰托拉克:癌症和炎症的结构增强和治疗见解

Muzaffar Kayumov^1,2,3, Fotima A Sobirova⁴, Okhunjon Khasanov⁵

¹Institute of Bioorganic Chemistry of Uzbekistan Academy of Sciences, Tashkent, Uzbekistan.

Natural product research

|October 10, 2025

概括

天然化合物阿兰托拉克 (ATL) 是一种有前途的抗癌和抗炎药物. 探索结构修改以提高其有效性并克服临床使用的局限性.

科学领域:

自然产品化学自然产品化学
药理学药理学是指药理学的学科.
药用化学医学化学

背景情况:

阿兰托拉克 (ATL) 是一种来自药用植物的甲烯乳,具有显著的抗癌和抗炎作用.
ATL在各种癌症细胞系中表现出生物活性,包括乳腺癌,肺癌,胃癌,胰腺癌,骨癌和肝癌.
目前ATL的临床应用受到水溶性差和非特异性蛋白质结合的阻碍.

研究的目的:

审查关于ATL生物活性的证据,重点关注抗癌和抗炎性质.
详细说明ATL在癌症和炎症中的作用机制.
总结结构转型方法,以优化ATL的有效性和减少副作用.

主要方法:

对ATL的生物活动和作用机制的文献综述.
对ATL应用的结构修改技术的分析.
检查最近在优化ATL的物理化学性质方面的进展.

主要成果:

ATL对多种癌症类型表现出强大的抗癌作用,并调节炎症过程.
确定的主要局限性包括溶解性差和非选择性结合.
各种化学反应 (如酸催化,循环添加,交叉合) 对于结构优化是有效的.

结论:

阿兰托拉克是一种有前途的天然抗癌剂,具有显著的抗炎性潜力.
结构优化策略对于克服ATL的局限性和提高其治疗疗效至关重要.
对改性ATL衍生物的进一步研究可能会导致改善的候选药物,并最大限度地减少副作用.

关键词:

亚兰托拉克顿是一种.这是一种抗炎药物.这是一种抗癌药物.结构转型结构转型

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...